CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2020	Mar. 31, 2020
Current assets
Cash	$ 14,473,232	$ 9,604,780
Accounts receivable	111,849	206,729
Prepaid expenses and other current assets	167,178	229,604
Total current assets	14,752,259	10,041,113
Property and equipment, net	145,855	140,484
Right-of-use lease asset	88,888	136,426
Patents, net	57,229	57,504
Deposits	12,159	12,159
Total assets	15,056,390	10,387,686
Current liabilities
Accounts payable	311,724	285,036
Due to related parties	156,909	111,707
Deferred revenue	507,022	100,000
Lease liability, current portion	92,603	98,557
Other current liabilities	421,502	472,420
Total current liabilities	1,489,760	1,067,720
Lease liability, less current portion	0	42,540
Total liabilities	1,489,760	1,110,260
Commitments and Contingencies (Note 13)
Stockholders' Equity
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 12,088,313 and 9,366,873 shares issued and outstanding as of September 30, 2020 and March 31, 2020, respectively	12,089	9,368
Additional paid-in capital	128,895,581	121,426,563
Accumulated deficit	(115,207,228)	(112,026,381)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests	13,700,442	9,409,550
Noncontrolling interests	(133,812)	(132,124)
Total stockholders' equity	13,566,630	9,277,426
Total liabilities and stockholders' equity	$ 15,056,390	$ 10,387,686